MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

Evalytics 29 January at 05.53 PM

'Cancer-cooling' protein puts bowel cancer on ice


Ku70 Activation: Ku70 can be activated to combat bowel cancer, offering a promising treatment approach.

DNA Damage Detection: Activated Ku70 can spot damaged DNA, a key cancer indicator, enhancing our understanding of cancer development.

Cancer Cell Suppression: Ku70 activation inhibits cancer cell aggressiveness and spread, potentially halting disease progression.

Improved Screening: Insights into Ku70's role may lead to more precise bowel cancer screening by measuring Ku70 levels in colon polyps.

Enhanced Prevention & Treatment: Understanding Ku70's immune biomarker role helps predict patient outcomes, emphasizing early detection's importance in bowel cancer management and potentially other cancers.

Read Full Article

Recent Comments


  • avatar